Log In
Print
BCIQ
Print
Print this Print this
 

BREVAGen

  Manage Alerts
Collapse Summary General Information
Company Genetic Technologies Ltd.
DescriptionBreast cancer stratification test that combines a DNA-based profile of breast cancer-associated SNPs with the patient's clinical history
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetermine a patient's 5-year risk for developing breast cancer; Determine the patient's lifetime and 5-year risk for developing breast cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today